Frontlight ResearchEarly access
CompletedPhase 2
Midodrine Effect on the Mortality Rates in Septic Shock Patients
Key facts
- Who runs it
- Noha Mansour
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- Phase
- Phase 2
- People taking part
- 100 people enrolled
- Started
- 7 Nov 2022
- Ended
- 24 Jan 2024
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Midodrine Oral Tablet
- Record updated
- 3 March 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Adult aged 18 years or older diagnosed with septic shock
- Hypotensive and require IV vasopressor for more than 24 hours
Who cannot take part
- Unable to administer an oral medication
- Known allergy to midodrine
- Severe organic heart disease (ejection fraction <30 percent)
- Chronic kidney disease (serum creatinine >2mg/dl)
- Hypovolemic shock
- Bradycardia (HR<50 b/m)
- Thyrotoxicosis
- Pheochromocytoma
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Assessing the safety and efficacy of the adjunctive use of midodrine as a vasopressor in septic shock patients by measuring the difference in the mortality rates between control and intervention groups.
The 2 groups in the trial
- ControlPlacebo, for comparison
Will receive IV vasopressor infusion only
Treatment: Midodrine Oral Tablet
- MidodrineExisting treatment, for comparison
Will receive oral midodrine 10 mg/ 8 hours in addition to IV vasopressor infusion till the end of treatment (subject remaining vasopressor-free for 24 consecutive hours).
Treatment: Midodrine Oral Tablet
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Clinical Study Evaluating the Efficacy and Safety of Adjunctive Use of Midodrine in Septic Shock Patients
- Publications
- Record updated
- 3 March 2025